Nesta página
PGEN Precigen, Inc. - Common Stock
NASDAQ · Biotechnology · Ver em SEC EDGAR ↗ fechar Out 5, 2026 10-K/10-Q Ago 4, 2026
$8,37
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$2,99mínima 52 sem
$8,98máxima 52 sem
Capitalização de Mercado (MRQ)
$2.99B
P/E
-6.1
EPS
$-1.37
Receita
$10M
seus distintivos
Intervalo 52 Semanas
$3–$9
Classificação do Analista
BUY
Preço-Alvo
$14
P/E
-6.1
ROE
3159.1%
Margem de Lucro Líquido
-2588.2%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
PGEN Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$8.37
Capitalização de Mercado (MRQ)
$2.99B
P/E
-6.1
EPS
$-1.37
Receita
$10M
ROE
3159.1%
Dívida/Capital (MRQ)
2.2
Intervalo 52 Semanas
$3–$9
PGEN Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Sobre Precigen, Inc. - Common Stock Visão geral da empresa da Wikipedia
Precigen, Inc. (formerly Intrexon Corporation, NASDAQ: PGEN) is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.
## History
In 2015, Intrexon purchased Oxitec, a maker of genetically sterile insects, for $160 million. In April 2019, Intrexon formed a subsidiary called Precigen, with a focus on human gene therapy. Precigen went on to win orphan drug status from the FDA for a CAR-T based therapy (investigational drug name PRGN-3006) to treat acute myeloid leukemia. In early 2020, Intrexon adopted the name of its subsidiary, Precigen, and narrowed its focus to human gene editing. With the change in name the CEO of subsidiary Precigen, Helen Sabzevari, took over leadership of the company from Randal J. Kirk.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
setorHealthcare
indústriaBiotechnology
funcionários160
paísUS
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$10M2016-12-31 → 2025-12-31
EPS$-1.372019-12-31 → 2025-12-31
Fluxo de caixa livre$-90M2016-12-31 → 2025-12-31
Margem líquida-2588.2%2016-12-31 → 2025-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | PGEN | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E | -6.1média 5A ≈-1.2 | ≈-1.2 | · | · | |
| P/S | 307.4média 5A ≈72.8 | ≈72.8 | 33.5 | Sobreavaliado | |
| P/B (MRQ) | 68.7média 5A ≈26.8 | ≈26.8 | 4.5 | Sobreavaliado | |
| EV / EBITDA | -27.7média 5A ≈25.0 | ≈25.0 | · | · | |
| Preço / FCF (TTM) | -26.0média 5A ≈-11.1 | ≈-11.1 | · | · | |
| Preço / Fluxo de Caixa (TTM) | -26.2média 5A ≈-11.8 | ≈-11.8 | · | · | |
| EV / Revenue (EV / Receita) | 306.9média 5A ≈74.0 | ≈74.0 | · | · | |
| EV / FCF (TTM) | -26.5média 5A ≈-11.3 | ≈-11.3 | · | · | |
| Preço / Valor Patrimonial Tangível (MRQ) | 73.0média 5A ≈131.6 | ≈131.6 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | PGEN | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Operating Margin (Margem Operacional) | -1141.1% | · | 12.3% | Primeira linha | |
| EBITDA Margin (Margem EBITDA) | -1108.1%média 5A ≈-351.6% | ≈-351.6% | 12.3% | Primeira linha | |
| Pretax Margin (Margem de Impostos Pré-Tributação) | -2588.2%média 5A ≈-992.9% | ≈-992.9% | 15.1% | Primeira linha | |
| Net Profit Margin (Margem de Lucro Líquido) | -2588.2%média 5A ≈-857.2% | ≈-857.2% | 10.2% | Primeira linha | |
| ROA | -166.7%média 5A ≈-61.4% | ≈-61.4% | -18.5% | Fraco | |
| ROE | 3159.1%média 5A ≈1034.3% | ≈1034.3% | -8.4% | Primeira linha | |
| ROIC | -96.9% | · | -31.0% | Fraco |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | PGEN | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido (MRQ) | 2.2média 5A ≈2.2 | ≈2.2 | · | · | |
| Índice de liquidez corrente (MRQ) | 4.6média 5A ≈3.0 | ≈3.0 | 6.5 | Baixa liquidez | |
| Índice de Liquidez Seca (MRQ) | 3.8média 5A ≈2.5 | ≈2.5 | 6.1 | Baixa liquidez | |
| Dívida de Longo Prazo / Patrimônio Líquido (MRQ) | 2.2média 5A ≈2.1 | ≈2.1 | · | · |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | PGEN | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 146.7%média 5A ≈13.2% | ≈13.2% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | -28.9%média 5A ≈-35.3% | ≈-35.3% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | -21.3% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | PGEN | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.1média 5A ≈0.2 | ≈0.2 | 0.1 | Fraco | |
| Receivables Turnover (Giro de Contas a Receber) | 4.0média 5A ≈11.0 | ≈11.0 | 7.1 | Fraco | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$60.5K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-66.6%
Próximo relatório
Nov 11, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 10, 2026 | $0.05 | $-0.01 | 467.6% |
| 31 de Março de 2026 | Mai 13, 2026 | $-0.02 | $-0.03 | 38.7% |
| 31 de Dezembro de 2025 | $-0.07 | $-0.09 | 17.6% | |
| 30 de Setembro de 2025 | $-1.06 | $-0.10 | -993.9% | |
| 30 de Junho de 2025 | $-0.09 | $-0.08 | -6.8% | |
| 31 de Março de 2025 | $-0.07 | $-0.08 | 14.2% | |
| 31 de Dezembro de 2024 | $-0.06 | $-0.06 | -4.0% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $4M | $6M | $27M | $14M | $32M | $91M | $151M | $231M | $191M | $174M | $72M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $33M | $38M | $41M | $11M | |
| R&D Expense | $41M | $53M | $49M | · | · | · | · | $405M | $143M | $112M | $147M | $59M | |
| SG&A Expense | $70M | $41M | $40M | · | · | · | · | $138M | $146M | $142M | $109M | $64M | |
| Operating Expenses | $120M | $139M | $106M | · | · | · | · | $666M | $369M | $316M | $320M | $142M | |
| Operating Income | $-111M | $-135M | $-100M | · | · | · | · | $-506M | $-138M | $-125M | $-147M | $-70M | |
| Interest Expense | · | · | · | · | · | · | · | $9M | $611.0K | $861.0K | $1M | $666.0K | |
| Other Non-op | $43.0K | $6M | $627.0K | · | · | · | · | $630.0K | $1M | $2M | $1M | $-168.0K | |
| Pretax Income | $-251M | $-128M | $-96M | $-80M | $-111M | $-105M | $-171M | $-396M | $-78M | $-194M | $-87M | $-86M | |
| Income Tax | $3.0K | $-2M | $-458.0K | $-189.0K | $-160.0K | $-82.0K | $-930.0K | $-15M | $2M | $-4M | $1M | $-103.0K | |
| Net Income | $-251M | $-126M | $-96M | $28M | $-92M | $-171M | $-322M | $-509M | $-117M | $-187M | $-84M | $-82M | |
| EPS (Basic) | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 | $-1.02 | $-2.09 | · | · | · | · | · | |
| EPS (Diluted) | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 | $-1.02 | $-2.09 | · | · | · | · | · | |
| Shares (Basic) | 312,980,562 | 267,727,426 | 244,536,221 | 200,360,821 | 197,759,900 | 167,065,539 | 154,138,774 | · | · | · | · | · | |
| Shares (Diluted) | 312,980,562 | 267,727,426 | 244,536,221 | 200,360,821 | 197,759,900 | 167,065,539 | 154,138,774 | · | · | · | · | · | |
| EBITDA | $-107M | · | · | $11M | $14M | $18M | $25M | $-472M | $-107M | $-101M | · | $-60M |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $30M | $8M | $5M | $36M | $52M | $66M | $97M | $68M | $63M | $136M | $27M | |
| Short-term Investments | $68M | $68M | $55M | $51M | $72M | $48M | $9M | $120M | $6M | $175M | $103M | $88M | |
| Receivables | $4M | $926.0K | $902.0K | $978.0K | $1M | $16M | $21M | $21M | $20M | $22M | $25M | $15M | |
| Prepaid Expense | $3M | $3M | $4M | $5M | $5M | $7M | $6M | $5M | $7M | $7M | $7M | $4M | |
| Current Assets | $115M | $102M | $69M | $118M | $157M | $149M | $235M | $285M | $154M | $315M | $324M | $175M | |
| PP&E (Net) | $14M | $14M | $7M | $7M | $9M | $35M | $44M | $87M | $113M | $65M | $43M | $38M | |
| PP&E (Gross) | $38M | $37M | $31M | $31M | $30M | $70M | $80M | $136M | $158M | $99M | $69M | $60M | |
| Accum. Depreciation | $24M | $23M | $24M | $23M | $21M | $35M | $36M | $49M | $46M | $34M | $26M | $22M | |
| Goodwill | $15M | $19M | $27M | $37M | $38M | $54M | $54M | $94M | $94M | $157M | $165M | $101M | |
| Intangibles | $3M | $4M | $41M | $44M | $52M | $65M | $68M | $89M | $233M | $226M | $248M | $66M | |
| Other Non-current Assets | $908.0K | $371.0K | $767.0K | $1M | $936.0K | $2M | $1M | $2M | $4M | $4M | $4M | $1M | |
| Total Assets | $156M | $145M | $151M | $216M | $360M | $315M | $456M | $716M | $847M | $949M | $982M | $576M | |
| Accounts Payable | $12M | $4M | $2M | $4M | $3M | $5M | $6M | $12M | $9M | $8M | $5M | $6M | |
| Short-term Debt | · | · | $0 | $43M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $37M | $22M | $23M | $79M | $35M | $42M | $123M | $62M | $80M | $95M | $76M | $47M | |
| Capital Leases | $4M | $5M | $6M | $7M | $9M | $8M | $10M | $0 | · | · | · | · | |
| Deferred Tax | · | $0 | $2M | $2M | $3M | $3M | $3M | $4M | $16M | $17M | $22M | $0 | |
| Other Non-current Liabilities | $134.0K | $0 | · | · | $50.0K | $100.0K | $0 | $3M | $3M | $4M | $795.0K | $699.0K | |
| Total Liabilities | $135M | $79M | $33M | $90M | $253M | $247M | $384M | $337M | $300M | $380M | $277M | $167M | |
| Long-term Debt | $93M | $0 | · | $43M | $180M | $172M | $218M | $212M | $8M | $8M | $9M | $10M | |
| Total Debt | $93M | · | · | $43M | $183M | $172M | $218M | $212M | $8M | $8M | · | $10M | |
| Paid-in Capital | $2.36B | $2.13B | $2.08B | $2.00B | $2.02B | $1.89B | $1.75B | $1.72B | $1.40B | $1.33B | $1.25B | $843M | |
| Retained Earnings | $-2.34B | $-2.09B | $-1.96B | $-1.87B | $-1.92B | $-1.82B | $-1.65B | $-1.33B | $-848M | $-729M | $-543M | $-458M | |
| AOCI | $7.0K | $12.0K | $-2M | $-3M | $203.0K | $4M | $-27M | $-29M | $-16M | $-36M | $-13M | $-4.0K | |
| Stockholders' Equity | $21M | $39M | $118M | $126M | $107M | $67M | $72M | $363M | $534M | $560M | $694M | $385M | |
| Liabilities + Equity | $156M | $145M | $151M | $216M | $360M | $315M | $456M | $716M | $847M | $949M | $982M | $576M | |
| Shares Outstanding | 353,910,926 | 292,869,097 | 248,919,096 | 208,150,021 | 206,739,874 | 187,663,207 | 163,274,880 | 160,020,466 | 122,087,040 | 118,688,770 | 116,658,886 | 100,557,932 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $5M | $7M | $11M | $14M | $18M | $25M | $33M | $31M | $25M | $18M | $10M | |
| Stock-based Comp | $11M | $9M | $10M | $10M | $14M | $18M | $19M | $36M | $42M | $42M | $39M | $22M | |
| Deferred Tax | $0 | $-2M | $-479.0K | $-150.0K | $-167.0K | $-156.0K | $-4M | $-21M | $-3M | $-3M | $1M | $0 | |
| Amort. of Intangibles | $1M | $3M | $5M | $5M | $5M | $5M | $8M | $12M | $11M | $15M | $10M | $4M | |
| Other Non-cash | $149M | · | · | $-114M | $9M | $58M | $146M | $337M | $-57M | $67M | · | $30M | |
| Operating Cash Flow | $-88M | $-68M | $-67M | $-65M | $-56M | $-77M | $-136M | $-124M | $-104M | $-49M | $36M | $-20M | |
| CapEx | $2M | $9M | $2M | $5M | $7M | $8M | $38M | $42M | $47M | $32M | $13M | $6M | |
| Investing Cash Flow | $-2M | $-21M | $-3M | $226M | $-75M | $28M | $87M | $-151M | $104M | $-28M | $-259M | $-26M | |
| Debt Issued | $93M | $0 | $0 | · | $0 | $0 | $376.0K | $220M | $325.0K | $547.0K | $81.0K | $268.0K | |
| Net Debt Issued | $93M | · | · | $-155M | $-466.0K | $-490.0K | $-242.0K | $219M | $-194.0K | $-654.0K | · | $-379.0K | |
| Stock Issued | $-355.0K | $31M | $73M | $0 | · | · | · | · | $0 | $0 | $328M | $0 | |
| Net Stock Activity | $-355.0K | · | · | · | · | · | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $90M | $111M | $30M | $-155M | $121M | $33M | $8M | $310M | $4M | $12M | $332M | $24M | |
| Net Change in Cash | $717.0K | $22M | $-41M | $5M | $-9M | $-16M | $-42M | $35M | $6M | $-66M | $108M | $-22M | |
| Free Cash Flow | $-90M | · | · | $-70M | $-63M | $-85M | $-174M | $-166M | $-151M | $-88M | · | $-26M | |
| Levered FCF | · | · | · | · | · | · | · | $-174M | $-151M | $-88M | · | $-27M |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1141.1% | · | · | · | · | · | · | · | -59.7% | -65.6% | · | -97.3% | |
| Net Margin | -2588.2% | · | · | 105.2% | -88.7% | -165.3% | · | · | -50.7% | -97.7% | · | -113.8% | |
| Pretax Margin | -2588.2% | · | · | -297.2% | -93.3% | -100.7% | · | · | -56.1% | -101.7% | · | -119.2% | |
| EBITDA Margin | -1108.1% | · | · | 40.0% | 13.2% | 17.0% | · | · | -46.2% | -52.7% | · | -82.8% | |
| ROA | -166.7% | · | · | 9.8% | -27.3% | -44.3% | -55.0% | -65.2% | -13.0% | -19.3% | · | -15.7% | |
| ROE | 3159.1% | · | · | 21.1% | -77.3% | -271.3% | -148.3% | -113.6% | -21.4% | -29.8% | · | -21.8% | |
| ROIC | -96.9% | · | · | · | · | · | · | -84.5% | -24.9% | -21.6% | · | -17.7% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | · | 1.5 | 4.5 | 3.5 | 1.9 | 4.6 | 1.9 | 3.3 | · | 3.7 | |
| Quick Ratio | 2.7 | · | · | 0.7 | 3.9 | 2.8 | 0.8 | 4.0 | 1.2 | 2.7 | · | 2.7 | |
| Debt / Equity | 4.5 | · | · | 0.3 | 1.7 | 2.6 | 3.0 | 0.6 | 0.0 | 0.0 | · | 0.0 | |
| LT Debt / Equity | 4.5 | · | · | 0.0 | 1.7 | 2.6 | 2.6 | 0.6 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | -59.3 | -225.7 | -145.4 | · | -105.0 |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | 0.1 | 0.3 | 0.3 | · | · | 0.3 | 0.2 | · | 0.1 | |
| Receivables Turnover | 4.0 | · | · | 23.4 | 5.6 | 5.6 | · | · | 11.2 | 8.2 | · | 9.4 |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.06 | · | · | $0.61 | $0.52 | $0.36 | $0.44 | $2.27 | $4.37 | $4.72 | · | $3.83 | |
| Revenue / Share | $0.03 | · | · | $0.13 | $0.53 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.28 | · | · | $-0.32 | $-0.28 | · | · | · | · | · | · | · | |
| Cash / Share | $0.09 | · | · | $0.02 | $0.21 | $0.28 | $0.40 | $0.64 | $0.56 | $0.53 | · | $0.27 | |
| EPS (TTM) | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 | $-1.02 | $-2.09 | $-1.54 | $-1.54 | $-1.54 | $-0.74 | $-0.84 |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 146.7% | -37.0% | -76.9% | 88.6% | -55.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -28.9% | -35.0% | -42.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -21.3% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $4M | $6M | $27M | $14M | $32M | $91M | $151M | $231M | $191M | $174M | $72M | |
| Net Income TTM | $-251M | $-126M | $-96M | $28M | $-92M | $-171M | $-322M | $-509M | $-117M | $-187M | $-84M | $-82M | |
| Market Cap | $1.48B | · | · | $316M | $767M | $1.91B | $895M | $1.05B | $1.41B | $2.86B | · | $2.65B | |
| Enterprise Value | $1.47B | · | · | $304M | $835M | $1.99B | $1.04B | $1.04B | $1.34B | $2.63B | · | $2.54B | |
| P/E | -3.1 | -2.4 | -3.4 | 10.9 | -7.9 | -10.0 | -2.6 | -4.2 | -7.5 | -15.6 | -40.4 | -31.3 | |
| P/S | 152.8 | · | · | 11.8 | 53.8 | 59.8 | 9.9 | 6.9 | 6.1 | 15.0 | · | 36.8 | |
| P/B | 70.7 | · | · | 2.5 | 7.1 | 28.5 | 12.5 | 2.9 | 2.6 | 5.1 | · | 6.9 | |
| P / Tangible Book | 592.5 | 8.0 | 6.5 | 7.0 | 43.8 | · | · | · | · | · | · | · | |
| P / Cash Flow | -16.8 | · | · | -4.9 | -13.8 | -24.9 | -6.6 | -8.4 | -13.5 | -51.1 | · | -133.2 | |
| P / FCF | -16.5 | · | · | -4.5 | -12.2 | -22.6 | -5.1 | -6.3 | -9.3 | -32.6 | · | -100.9 | |
| EV / EBITDA | -13.7 | · | · | 28.2 | 60.7 | 113.4 | 41.7 | -2.2 | -12.6 | -26.1 | · | -42.7 | |
| EV / FCF | -16.4 | · | · | -4.3 | -13.3 | -23.5 | -6.0 | -6.2 | -8.9 | -30.0 | · | -96.8 | |
| EV / Revenue | 152.3 | · | · | 11.3 | 58.5 | 62.1 | 11.4 | 6.9 | 5.8 | 13.8 | · | 35.3 | |
| Earnings Yield | -32.8% | -42.0% | -29.1% | 9.2% | -12.7% | -10.0% | -38.1% | -23.5% | -13.4% | -6.4% | -2.5% | -3.2% |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $55M | $23M | · | · | $856.0K | $1M | · | · | · | · | · | · | $2M | $2M | · | $17M | |
| R&D Expense | $7M | $6M | · | · | $11M | $10M | · | · | · | · | · | · | · | · | · | · | |
| SG&A Expense | $22M | $21M | · | · | $16M | $12M | · | · | · | · | · | · | · | · | · | · | |
| Operating Expenses | $32M | $29M | · | · | $33M | $24M | · | · | · | · | · | · | · | · | · | · | |
| Operating Income | $23M | $-6M | · | · | $-32M | $-23M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $16.0K | $290.0K | · | · | $-31.0K | $7.0K | · | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $20M | $-8M | · | · | $-27M | $-54M | $-20M | $-24M | $-60M | $-24M | $-33M | $-20M | $-20M | $-23M | $-22M | $-8M | |
| Income Tax | $0 | $0 | $0 | $0 | $3.0K | $0 | $-87.0K | $12.0K | $-2M | $-29.0K | $-332.0K | $-6.0K | $-65.0K | $-55.0K | $8.0K | $-50.0K | |
| Net Income | $20M | $-8M | $-24M | $-146M | $-27M | $-54M | $-20M | $-24M | $-59M | $-24M | $-33M | $-20M | $-20M | $-23M | $-22M | $87M | |
| EPS (Basic) | $0.06 | $-0.02 | $-0.04 | $-1.06 | $-0.09 | $-0.18 | $-0.05 | $-0.09 | $-0.23 | $-0.10 | $-0.13 | $-0.08 | $-0.08 | $-0.10 | $-0.11 | $0.44 | |
| EPS (Diluted) | $0.05 | $-0.02 | $-0.04 | $-1.06 | $-0.09 | $-0.18 | $-0.05 | $-0.09 | $-0.23 | $-0.10 | $-0.13 | $-0.08 | $-0.08 | $-0.10 | $-0.11 | $0.44 | |
| Shares (Basic) | 356,893,568 | 354,291,007 | · | 307,170,490 | 296,434,726 | 293,879,653 | · | 275,881,170 | 252,366,533 | 249,220,335 | · | 248,520,724 | 248,003,322 | 229,770,381 | · | 200,670,590 | |
| Shares (Diluted) | 413,686,865 | 354,291,007 | · | 307,170,490 | 296,434,726 | 293,879,653 | · | 275,881,170 | 252,366,533 | 249,220,335 | · | 248,520,724 | 248,003,322 | 229,770,381 | · | 200,670,590 | |
| EBITDA | $23M | $-5M | · | · | · | $629.0K | · | · | · | $2M | · | · | · | $2M | · | · |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $7M | $30M | $14M | $14M | $6M | $30M | $25M | $9M | $17M | · | $10M | $17M | $10M | · | $9M | |
| Short-term Investments | $22M | $49M | $68M | $107M | $46M | $74M | $68M | $4M | $10M | $27M | · | $64M | $72M | $94M | · | $62M | |
| Receivables | $72M | $26M | $4M | $580.0K | $327.0K | $751.0K | $926.0K | $479.0K | $511.0K | $872.0K | · | $988.0K | $1M | $2M | · | $1M | |
| Prepaid Expense | $4M | $4M | $3M | $4M | $2M | $3M | $3M | $5M | $3M | $4M | · | $5M | $3M | $4M | · | $6M | |
| Current Assets | $134M | $102M | $115M | $130M | $63M | $85M | $102M | $35M | $24M | $50M | · | $93M | $106M | $138M | · | $163M | |
| PP&E (Net) | $13M | $13M | $14M | $15M | $15M | $15M | $14M | $14M | $13M | $13M | · | $7M | $7M | $7M | · | $8M | |
| PP&E (Gross) | $38M | $38M | $38M | $38M | $37M | $38M | $37M | $36M | $36M | $37M | · | $31M | $31M | $31M | · | $30M | |
| Accum. Depreciation | $25M | $25M | $24M | $23M | $23M | $23M | $23M | $23M | $22M | $25M | · | $24M | $24M | $24M | · | $23M | |
| Goodwill | $15M | $15M | $15M | $15M | $15M | $19M | $19M | $25M | $25M | $27M | $27M | $37M | $37M | $37M | $37M | $37M | |
| Intangibles | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $39M | · | $40M | $43M | $44M | · | $42M | |
| Other Non-current Assets | $708.0K | $782.0K | $908.0K | $753.0K | $590.0K | $427.0K | $371.0K | $425.0K | $435.0K | $751.0K | · | $797.0K | $949.0K | $1M | · | $871.0K | |
| Total Assets | $170M | $139M | $156M | $171M | $102M | $129M | $145M | $83M | $73M | $135M | · | $191M | $208M | $242M | · | $259M | |
| Accounts Payable | $5M | $3M | $12M | $6M | $4M | $3M | $4M | $4M | $5M | $5M | · | $2M | $3M | $4M | · | $4M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $14M | · | · | |
| Current Liabilities | $29M | $21M | $37M | $32M | $23M | $24M | $22M | $21M | $23M | $29M | · | $33M | $31M | $47M | · | $105M | |
| Capital Leases | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | · | $6M | $7M | $7M | · | $8M | |
| Deferred Tax | · | · | · | · | · | · | · | $89.0K | $77.0K | $2M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Liabilities | $77.0K | $106.0K | $134.0K | $163.0K | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $127M | $118M | $135M | $129M | $108M | $113M | $79M | $28M | $30M | $38M | · | $43M | $41M | $57M | · | $117M | |
| Long-term Debt | $94M | $94M | $93M | $93M | · | · | $0 | · | · | · | · | · | · | · | · | $82M | |
| Total Debt | $94M | $94M | · | · | · | · | · | · | · | · | · | $0 | $0 | $14M | · | $82M | |
| Paid-in Capital | $2.37B | $2.37B | $2.36B | $2.36B | $2.13B | $2.13B | $2.13B | $2.13B | $2.09B | $2.09B | · | $2.08B | $2.08B | $2.08B | · | $2.00B | |
| Retained Earnings | $-2.33B | $-2.35B | $-2.34B | $-2.32B | $-2.17B | $-2.14B | $-2.09B | $-2.07B | $-2.05B | $-1.99B | · | $-1.93B | $-1.91B | $-1.89B | · | $-1.85B | |
| AOCI | $-29.0K | $-17.0K | $7.0K | $24.0K | $11.0K | $12.0K | $12.0K | $13.0K | $-3M | $-3M | · | $-4M | $-3M | $-3M | · | $-7M | |
| Stockholders' Equity | $44M | $20M | $21M | $42M | $-37M | $-14M | $39M | $55M | $43M | $97M | $118M | $148M | $166M | $184M | $126M | $143M | |
| Liabilities + Equity | $170M | $139M | $156M | $171M | $102M | $129M | $145M | $83M | $73M | $135M | · | $191M | $208M | $242M | · | $259M | |
| Shares Outstanding | 358,008,798 | 355,903,977 | 353,910,926 | 353,810,556 | 297,846,160 | 295,135,060 | 292,869,097 | 292,869,097 | 252,656,151 | 250,248,808 | 248,919,096 | 256,398,527 | 255,482,753 | 255,482,753 | 208,150,021 | 208,150,021 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $803.0K | $630.0K | $629.0K | $661.0K | $674.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Stock-based Comp | $4M | $3M | $2M | $4M | $2M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | $-89.0K | $12.0K | $-2M | $-29.0K | $-353.0K | $-13.0K | $-58.0K | $-55.0K | $12.0K | $-50.0K | |
| Amort. of Intangibles | $319.0K | $318.0K | $318.0K | $318.0K | $318.0K | $319.0K | $318.0K | $318.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Other Non-cash | · | $-40M | · | · | · | $35M | · | · | · | $6M | · | · | · | $-441.0K | · | · | |
| Operating Cash Flow | $-18M | $-44M | $-23M | $-29M | $-19M | $-16M | $-8M | $-23M | $-23M | $-14M | $-16M | $-17M | $-16M | $-18M | $-15M | $-24M | |
| CapEx | $392.0K | $258.0K | $18.0K | $389.0K | $966.0K | $622.0K | $1M | $882.0K | $2M | $4M | $1M | $236.0K | $101.0K | $154.0K | $53.0K | $2M | |
| Investing Cash Flow | $27M | $21M | $40M | $-63M | $28M | $-6M | $-65M | $6M | $15M | $24M | $13M | $11M | $24M | $-50M | $11M | $182M | |
| Debt Issued | · | · | $-654.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-29M | · | · | |
| Stock Issued | $0 | $0 | $0 | $0 | $0 | $-355.0K | $-596.0K | $32M | $0 | $0 | $0 | $0 | $-693.0K | $74M | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-355.0K | · | · | · | $0 | · | · | · | $74M | · | · | |
| Financing Cash Flow | $-33.0K | $109.0K | $-514.0K | $93M | $-2M | $-679.0K | $78M | $32M | $52.0K | $0 | $0 | $0 | $-15M | $44M | $-39M | $-116M | |
| Net Change in Cash | $9M | $-23M | $16M | $562.0K | $8M | $-23M | $5M | $15M | $-8M | $10M | $-2M | $-7M | $-7M | $-25M | $-43M | $42M | |
| Free Cash Flow | · | $-44M | · | · | · | $-17M | · | · | · | $-18M | · | · | · | $-19M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.2% | -25.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | 36.5% | -34.1% | · | · | · | · | · | · | · | · | · | · | -1149.9% | -1228.2% | · | 522.5% | |
| Pretax Margin | 36.5% | -34.1% | · | · | · | · | · | · | · | · | · | · | -1153.6% | -1231.2% | · | -46.0% | |
| EBITDA Margin | 41.2% | -21.1% | · | · | · | · | · | · | · | · | · | · | · | 92.4% | · | · | |
| ROA | 14.8% | -5.9% | · | -114.9% | -30.4% | -41.1% | · | -17.5% | -41.9% | -12.6% | · | -8.8% | -7.7% | -7.9% | · | 27.5% | |
| ROE | 590.6% | -256.8% | · | -301.0% | -833.7% | -130.6% | · | -23.6% | -56.2% | -16.9% | · | -13.6% | -18.3% | -17.6% | · | 63.8% | |
| ROIC | 16.5% | -5.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 4.8 | · | 4.0 | 2.7 | 3.5 | · | 1.6 | 1.0 | 1.7 | · | 2.8 | 3.4 | 2.9 | · | 1.6 | |
| Quick Ratio | 3.8 | 3.9 | · | 3.8 | 2.6 | 3.4 | · | 1.4 | 0.9 | 1.6 | · | 2.3 | 2.9 | 2.3 | · | 0.7 | |
| Debt / Equity | 2.2 | 4.6 | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.1 | · | 0.6 | |
| LT Debt / Equity | 2.2 | 4.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.2 | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.7 | · | · | · | · | · | · | · | · | · | · | 1.3 | 0.1 | · | 1.6 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.12 | $0.06 | · | $0.12 | $-0.12 | $-0.05 | · | $0.19 | $0.17 | $0.39 | · | $0.58 | $0.65 | $0.72 | · | $0.68 | |
| Revenue / Share | $0.13 | $0.07 | · | · | · | · | · | · | · | · | · | · | $0.01 | $0.01 | · | $0.08 | |
| Cash Flow / Share | · | $-0.12 | · | · | · | $-0.06 | · | · | · | $-0.06 | · | · | · | $-0.08 | · | · | |
| Cash / Share | $0.05 | $0.02 | · | $0.04 | $0.05 | $0.02 | · | $0.08 | $0.04 | $0.07 | · | $0.04 | $0.06 | $0.04 | · | $0.04 | |
| EPS (TTM) | $-1.07 | $-1.21 | · | $-1.38 | $-0.41 | $-0.55 | · | $-0.55 | $-0.54 | $-0.39 | · | $-0.37 | $0.15 | $0.14 | · | $0.12 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-158M | $-204M | · | $-247M | $-124M | $-157M | · | $-140M | $-135M | $-97M | · | $-85M | $22M | $25M | · | $25M | |
| Market Cap | $2.04B | $1.38B | · | $1.16B | $423M | $440M | · | $278M | $399M | $363M | · | $364M | $294M | $271M | · | $441M | |
| Enterprise Value | $2.10B | $1.41B | · | · | · | · | · | · | · | · | · | $290M | $205M | $181M | · | $452M | |
| P/E | -5.3 | -3.2 | · | -2.4 | -3.5 | -2.7 | · | -1.7 | -2.9 | -3.7 | · | -3.8 | 7.7 | 7.6 | · | 17.7 | |
| P/B | 46.8 | 68.1 | · | 27.8 | -11.5 | -31.3 | · | 5.0 | 9.2 | 3.7 | · | 2.5 | 1.8 | 1.5 | · | 3.1 | |
| P / Tangible Book | 79.1 | 643.9 | · | 50.3 | · | · | · | 10.8 | 30.3 | 11.4 | · | 5.2 | 3.4 | 2.6 | · | 7.0 | |
| P / Cash Flow | · | -31.4 | · | · | · | -26.9 | · | · | · | -25.8 | · | · | · | -14.7 | · | · | |
| Earnings Yield | -18.8% | -31.3% | · | -41.9% | -28.9% | -36.9% | · | -57.9% | -34.2% | -26.9% | · | -26.1% | 13.0% | 13.2% | · | 5.7% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $10M | $4M | $6M | $27M | $14M |
| Margem Operacional % | -1141.1% | · | · | · | · |
| Lucro líquido | $-251M | $-126M | $-96M | $28M | $-92M |
| EPS Diluído | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 4.5 | · | · | 0.3 | 1.7 |
| Índice de liquidez corrente | 3.1 | · | · | 1.5 | 4.5 |
| Índice de Liquidez Seca | 2.7 | · | · | 0.7 | 3.9 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-90M | · | · | $-70M | $-63M |
Investidores institucionais (13F) 235 declarantes · $868.3M total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
235
Valor detido
$868.3M
Novas posições
40
Posições encerradas
26
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 40 (-10 vs trimestre anterior) | 26 (+10 vs trimestre anterior) | 89 (+18 vs trimestre anterior) | 46 (-3 vs trimestre anterior) | +8.5M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Patient Capital Management, LLC | $108.510.760 | 19.036.976 | 12,50% | Ações |
| BlackRock, Inc. | $97.737.450 | 17.146.921 | 11,26% | Ações |
| STATE STREET CORP | $68.414.051 | 12.002.465 | 7,88% | Ações |
| Diametric Capital, LP | $52.838.578 | 9.269.926 | 6,09% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $45.065.112 | 7.906.160 | 5,19% | Ações |
| VANGUARD GROUP INC | $43.804.109 | 10.479.452 | 5,04% | Ações |
| TANG CAPITAL MANAGEMENT LLC | $36.579.750 | 6.417.500 | 4,21% | Ações |
| Boxer Capital Management, LLC | $29.355.000 | 5.150.000 | 3,38% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $28.612.911 | 5.019.028 | 3,30% | Ações |
| IRIDIAN ASSET MANAGEMENT LLC/CT | $22.982.189 | 4.031.963 | 2,65% | Ações |
| MORGAN STANLEY | $19.776.885 | 3.469.628 | 2,28% | Ações |
| Occam Crest Management LP | $19.652.378 | 3.605.941 | 2,26% | Ações |
| GOLDMAN SACHS GROUP INC | $19.416.797 | 3.406.456 | 2,24% | Ações |
| FMR LLC | $14.650.046 | 2.570.183 | 1,69% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.603.680 | 2.211.172 | 1,45% | Ações |
| FIRST TRUST ADVISORS LP | $11.483.556 | 2.014.659 | 1,32% | Ações |
| BANK OF AMERICA CORP /DE/ | $10.535.960 | 1.848.414 | 1,21% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10.192.940 | 1.788.235 | 1,17% | Ações |
| NORTHERN TRUST CORP | $10.142.467 | 1.779.380 | 1,17% | Ações |
| Caption Management, LLC | $9.690.000 | 1.700.000 | 1,12% | Opção de venda |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8.640.362 | 1.515.853 | 1,00% | Ações |
| Diametric Capital, LP | $8.048.400 | 1.412.000 | 0,93% | Opção de compra |
| Woodline Partners LP | $7.991.087 | 1.401.945 | 0,92% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $7.386.904 | 1.295.948 | 0,85% | Ações |
| Point72 Asset Management, L.P. | $7.220.070 | 1.266.679 | 0,83% | Ações |
| FRANKLIN RESOURCES INC | $5.846.205 | 1.025.650 | 0,67% | Ações |
| BARCLAYS PLC | $5.308.799 | 931.368 | 0,61% | Ações |
| Caption Management, LLC | $5.130.000 | 900.000 | 0,59% | Ações |
| JPMORGAN CHASE & CO | $5.077.625 | 849.298 | 0,58% | Ações |
| PRELUDE CAPITAL MANAGEMENT, LLC | $5.028.922 | 882.267 | 0,58% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.023.410 | 881.300 | 0,58% | Opção de compra |
| CITADEL ADVISORS LLC | $4.676.217 | 820.389 | 0,54% | Ações |
| UBS Group AG | $4.438.949 | 778.763 | 0,51% | Ações |
| CITIGROUP INC | $4.131.856 | 724.887 | 0,48% | Ações |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $4.025.876 | 706.294 | 0,46% | Ações |
| Nuveen, LLC | $4.006.154 | 702.834 | 0,46% | Ações |
| GMT Capital Corp | $3.812.331 | 668.830 | 0,44% | Ações |
| LexAurum Advisors, LLC | $3.638.954 | 638.413 | 0,42% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $3.450.210 | 605.300 | 0,40% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.430.511 | 601.844 | 0,40% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $3.164.811 | 555.230 | 0,36% | Ações |
| RAYMOND JAMES FINANCIAL INC | $2.943.091 | 516.332 | 0,34% | Ações |
| CIBC Bancorp USA Inc. | $2.849.498 | 499.912 | 0,33% | Ações |
| Lansing Street Advisors | $2.823.905 | 495.422 | 0,33% | Ações |
| Bank of New York Mellon Corp | $2.704.635 | 474.497 | 0,31% | Ações |
| Swiss National Bank | $2.226.420 | 390.600 | 0,26% | Ações |
| Cetera Investment Advisers | $2.209.947 | 387.710 | 0,25% | Ações |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $2.175.222 | 381.618 | 0,25% | Ações |
| PEAK6 LLC | $2.100.450 | 368.500 | 0,24% | Opção de compra |
| Persistent Asset Partners Ltd | $2.027.872 | 355.767 | 0,23% | Ações |
Ativistas e proprietários de 5%+ 3 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| RANDAL J. KIRK, R.J. KIRK DECLARATION OF TRUST, THIRD SECURITY, LLC ×21 declarações | 31 de Março de 2026 | 35,90% | Emenda | · | SEC |
| 6 de Janeiro de 2020 | · | Declaração inicial | · | SEC | |
| 23 de Outubro de 2017 | · | Declaração inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 40 insiders · 16 diretores · 10 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Helen Sabzevari | President and CEO | 23 de Agosto de 2026 M | 3.779.521 | 0 | 2 | $-2.562.794 |
| Harry Thomasian Jr. | Chief Financial Officer | 23 de Setembro de 2026 M | 311.914 | 0 | 4 | $-1.901.756 |
| Rick L. Sterling | Chief Financial Officer | 4 de Janeiro de 2021 M | 340.020 | 0 | 0 | $0 |
| Rutul R Shah | Chief Operating Officer | 25 de Agosto de 2026 M | 468.865 | 0 | 6 | $-1.256.398 |
| Thomas Bostick | Chief Operating Officer | 4 de Janeiro de 2020 M | 74.280 | 0 | 0 | $0 |
| Phil Tennant | Chief Commercial Officer | 25 de Agosto de 2026 M | 141.992 | 0 | 2 | $-725.731 |
| Donald P. Lehr | Chief Legal Officer | 23 de Agosto de 2026 M | 758.181 | 0 | 1 | $-127.011 |
| Jeffrey Thomas Perez | SVP, IP Affairs | 9 de Agosto de 2024 P | 743.097 | 0 | 0 | $0 |
| Bradford D. Osborne | VP, Finance and Accounting | 21 de Abril de 2021 A | · | 0 | 0 | $0 |
| Thomas D. Reed | Chief Science Officer | 4 de Janeiro de 2020 M | 148.888 | 0 | 0 | $0 |
| Robert F. Walsh III | SVP, Energy & Fine Chem. | 30 de Junho de 2019 M | 28.816 | 0 | 0 | $0 |
| Nir Nimrodi | Chief Business Officer | 4 de Janeiro de 2019 A | 19.482 | 0 | 0 | $0 |
| Joel D Liffman | SVP, Finance | 4 de Janeiro de 2019 A | 99.315 | 0 | 0 | $0 |
| Kelly Huang | SVP-Consumer Sector | 9 de Maio de 2014 P | 3.200 | 0 | 0 | $0 |
| Thomas R. Kasser | SVP--Food Sector | 9 de Maio de 2014 P | 15.000 | 0 | 0 | $0 |
| Darryl Webster | SVP--Intellectual Property | 20 de Março de 2014 A | 9.132 | 0 | 0 | $0 |
| Jeffrey B Kindler | Conselheiro | 26 de Agosto de 2026 S | 17.100 | 0 | 2 | $-2.231.145 |
| Nancy H Agee | Conselheiro | 21 de Agosto de 2026 P | 309.187 | 1 | 0 | $24.662 |
| RANDAL J. KIRK | Conselheiro | 30 de Março de 2026 S | 12.262.741 | 0 | 25 | $-35.984.076 |
| Vinita D Gupta | Conselheiro | 13 de Março de 2026 M | 666.027 | 0 | 0 | $0 |
| Steven Frank | Conselheiro | 13 de Março de 2026 M | 1.226.391 | 0 | 0 | $0 |
| James S Turley | Conselheiro | 13 de Março de 2026 M | 685.417 | 0 | 0 | $0 |
| Cesar L Alvarez | Conselheiro | 13 de Março de 2026 M | 782.909 | 0 | 0 | $0 |
| Fred Hassan | Conselheiro | 13 de Março de 2026 M | 1.243.239 | 0 | 0 | $0 |
| Dean J Mitchell | Conselheiro | 14 de Março de 2024 A | 503.183 | 0 | 0 | $0 |
| Robert B Shapiro | Conselheiro | 9 de Março de 2023 A | 329.656 | 0 | 0 | $0 |
| Trading S.A. Ares | Detentor de 10% | 13 de Outubro de 2021 S | 20.647.152 | 0 | 0 | $0 |
| Andrew J. Last | · | 13 de Novembro de 2017 P | 4.000 | 0 | 0 | $0 |
| Geno J Germano | · | 22 de Setembro de 2016 A | · | 0 | 0 | $0 |
| Suma Krishnan | · | 29 de Janeiro de 2016 M | 56.657 | 0 | 0 | $0 |
| Krish S Krishnan | · | 29 de Janeiro de 2016 M | 56.657 | 0 | 0 | $0 |
| Ena Chan Cratsenburg | · | 7 de Janeiro de 2016 A | · | 0 | 0 | $0 |
| INTREXON CORP | · | 7 de Janeiro de 2016 A | · | 0 | 0 | $0 |
| Joseph L Vaillancourt | · | 19 de Outubro de 2015 A | · | 0 | 0 | $0 |
| Corey Huck | · | 12 de Outubro de 2015 A | · | 0 | 0 | $0 |
| Samuel Broder | · | 21 de Julho de 2015 A | · | 0 | 0 | $0 |
| Jack A Bobo | · | 20 de Julho de 2015 A | · | 0 | 0 | $0 |
| Olivier Roger Jarry | · | 11 de Junho de 2015 A | · | 0 | 0 | $0 |
| Gregory Ian Frost | · | 28 de Maio de 2015 M | 300.000 | 0 | 0 | $0 |
| HORNER LARRY D /FA | · | 12 de Março de 2015 A | 68.507 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 29 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,94% | 304.977 NS | 31 de Julho de 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,74% | 1.539.558 NS | 31 de Julho de 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,62% | 17.299 SH | 2 de Outubro de 2026 | Diário |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,40% | 198.876 SH | 2 de Outubro de 2026 | Diário |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,35% | 765.206 NS | 31 de Julho de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,31% | 240.763 NS | 31 de Julho de 2026 | N-PORT |
| IWC · iShares Trust | 0,30% | 655.175 SH | 11 de Setembro de 2026 | Diário |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,20% | 25.265 SH | 2 de Outubro de 2026 | Diário |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,15% | 139.467 NS | 31 de Julho de 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,09% | 3.289 NS | 31 de Julho de 2026 | N-PORT |
| IWO · iShares Trust | 0,08% | 1.802.964 SH | 11 de Setembro de 2026 | Diário |
| VFMO · VANGUARD WELLINGTON FUND | 0,08% | 292.277 SH | 19 de Agosto de 2026 | Diário |
| IBB · iShares Trust | 0,08% | 1.205.825 SH | 11 de Setembro de 2026 | Diário |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 206.995 SH | 19 de Agosto de 2026 | Diário |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 49.171 NS | 31 de Julho de 2026 | N-PORT |
| IWM · iShares Trust | 0,04% | 4.946.547 SH | 11 de Setembro de 2026 | Diário |
| RSSL · Global X Funds | 0,04% | 92.222 NS | 31 de Julho de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 1.111.545 SH | 19 de Agosto de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,02% | 585.833 SH | 19 de Agosto de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 92.500 NS | 31 de Julho de 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 22.110 SH | 11 de Setembro de 2026 | Diário |
| WSML · iShares Trust | 0,01% | 10.765 SH | 11 de Setembro de 2026 | Diário |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 2.042.450 SH | 19 de Agosto de 2026 | Diário |
| IWV · iShares Trust | 0,00% | 62.200 SH | 9 de Setembro de 2026 | Diário |
| ITOT · iShares Trust | 0,00% | 286.766 SH | 11 de Setembro de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5.690.796 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 14.522 SH | 19 de Agosto de 2026 | Diário |
| ISCB · iShares Trust | · | 8.008 SH | 11 de Setembro de 2026 | Diário |
| ISCV · iShares Trust | · | 25.549 SH | 11 de Setembro de 2026 | Diário |
PGEN Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 9 analistas
COMPRA
Alvo mediano
$12.00
+43,5%
2 22,2%
Compra forte
5 55,6%
Compra
2 22,2%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
3 analistas · 2026-10-01Alvo médio $13.65 +63,2%
← Abaixo de todos os alvos
Preço atual $8.37
Mín$11.00
Média$13.65
Máx$17.95
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | · |
| IRON | $3.01B | -13.2 | · | · | -31.3% | · |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 4, 2026